A clinical study to evaluate the effects of a fat cell targeted gel for body skin laxity

ISRCTN ISRCTN11066382
DOI https://doi.org/10.1186/ISRCTN11066382
Sponsor Adipeau Inc.
Funder Adipeau Inc.
Submission date
09/02/2026
Registration date
13/02/2026
Last edited
13/02/2026
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Plain English summary of protocol not provided at time of registration

Contact information

Mr Ivan Galanin
Public, Scientific, Principal investigator

8 East 96th Street
New York
10128
United States of America

ORCiD logoORCID ID 0000-0002-8991-9552
Phone +1 718-750-1492
Email ivan@adipeau.com

Study information

Primary study designInterventional
AllocationN/A: single arm study
MaskingOpen (masking not used)
ControlUncontrolled
AssignmentSingle
PurposeTreatment
Scientific titleA clinical study to validate the laxity reduction effects of a dual-acting lipolytic/adipogenic gel
Study objectivesThis study will evaluate whether a gel that improves the fitness of skin fat cells can improve the appearance of weak skin on the legs and buttocks. The study aims to demonstrate improvement in laxity severity at Week 12 compared to baseline.
Ethics approval(s)Ethics approval not required
Health condition(s) or problem(s) studiedHealthy adults
InterventionStrength Gel (Adipeau Inc), a marketed topical cosmetic containing Kaempferia Parviflora Extract as an active ingredient, was applied by participants 2x per day in a thin layer to areas of skin laxity.
Intervention typeOther
Primary outcome measure(s)
  1. Laxity severity measured using the Laxity Scale at baseline and 3 months
Key secondary outcome measure(s)
  1. Objective skin texture measurement measured using selected outputs of Antera 3D imaging (e.g., skin texture, large wrinkles, dimpling, elevations) at baseline and 3 months
Completion date14/08/2026

Eligibility

Participant type(s)
Age groupMixed
Lower age limit45 Years
Upper age limit75 Years
SexFemale
Target sample size at registration30
Total final enrolment35
Key inclusion criteriaModerate to severe skin laxity on the legs and/or buttocks.
Key exclusion criteriaAnticipated changes to body composition through new exercise regimens, weight loss or major lifestyle changes.
Date of first enrolment13/02/2026
Date of final enrolment14/05/2026

Locations

Countries of recruitment

  • Australia
  • United States of America

Study participating centres

Ageless Aesthetics by HB Walsh
650 Berkeley Ave
Berkeley Township
08721
United States of America
South County Microspa
195 Montana Del Lago Drive
Rancho Santa Margarita
92688
United States of America
Advanced Skin by Summer
50 Tallis Drive
Mornington
3931
Australia

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planAll de-identified cropped images used in the analysis of efficacy endpoints to be made available to researchers.

Editorial Notes

13/02/2026: Study’s existence confirmed by the Ageless Aesthetics by HB Walsh, USA.